Arsenal Biosciences, Inc. is a clinical stage, programmable cell therapy company focused on developing solid tumor cell therapies to defeat cancer. Leveraging a diverse team of experts across multiple scientific disciplines and clinical and manufacturing experience, ArsenalBio is committed to engineering innovative treatments that target the complex nature of cancer. Utilizing a programmable and computationally driven approach, the company aims to improve patient outcomes by overcoming the challenges of solid tumors through advanced cell therapies.
Biotechnology β’ technology β’ artificial intelligence β’ cancer β’ immunology
201 - 500 employees
𧬠Biotechnology
βοΈ Healthcare Insurance
π Pharmaceuticals
π₯ Funding within the last year
π° Series C on 2024-09
October 25
201 - 500
𧬠Biotechnology
βοΈ Healthcare Insurance
π Pharmaceuticals
Spearhead regulatory affairs for CAR T-cell therapies at ArsenalBio.
πΊπΈ United States β Remote
π΅ $285.7k - $350k / year
π₯ Funding within the last year
π° Series C on 2024-09
β° Full Time
π΄ Lead
π Compliance